SavedAdd your journal

Journals / Turkish Journal of Cancer / 2001 / Cilt: 31 - Sayı: 3

Late onset of distant metastases from breast cancer

Özlem ER
H. Şenol COŞKUN
Işın SOYUER
Mustafa ALTINBAŞ
Pages
125–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Late recurrence is thought to be due to cancer cells being in a 'dormant' state.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is the most frequently diagnosed cancer in females and characterized by long duration and heterogeneity among patients.
📊
Key Findings & Data:A 65 year old female patient presented with growing mass in left side of neck, loss of appetite and weight loss.
💡
Conclusion & Impact:Late recurrence is thought to be due to cancer cells being in a 'dormant' state.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Meme neoplazmları · Neoplazm metastazı · Neoadjuvant tedavi

Abstract

Breast cancer is the most frequently diagnosed cancer in females and characterized by long duration and heterogeneity among patients. Even in early stage breast cancer, probability of local recurrence and metastasis in long period should be considered. A 65 year old female patient presented with growing mass in left side of neck, loss of appetite and weight loss. Past medical history revealed a right breast cancer treated by right modified radical mastectomy and adjuvant chemotherapy consisting of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) 15 years ago. This patient's presentation was late-onset of lymph node, pleura and lung metastases. Metastases 15 years after diagnosis of the primary tumor is uncommon. Late recurrence is thought to be due to cancer cells being in a 'dormant' state.

Özet

Late onset of distant metastases from breast cancer

🔖

Cite This Article

ER, Ö., COŞKUN, H. Ş., SOYUER, I., ALTINBAŞ, M. (2001). Late onset of distant metastases from breast cancer. Turkish Journal of Cancer, Cilt: 31 - Sayı: 3, 125–130. https://ajindex.com/articles/368393

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Haskell CM, Barsky SH, Bassett LW, et al. Natural history and pretreatment assessment of breast cancer. In: Haskell CM, editor. Cancer Treatment. 4th ed. Philadelphia: Saunders, 1995;324-37
  2. Cocconi G. The natural history of operable breast cancer after primary treatment. Ann Oncol 1995;6(Suppl 2):11-21
  3. Margolese RG, Fisher B, Hortobagyi G, et al. Neoplasms of the breast. In: Holland Frei, editor. Cancer Medicine. 5th ed. Canada: B.C. Decker Inc, 2000;1735-822
  4. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1998;90:1601-8
  5. Schwartzberg LS, Birch R, Tawer KW, et al. Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes. Am J Clin Oncol 1999;22:136-142
  6. Baltalı E. Erken evre meme kanserlerinde adjuvan tedavi prensipleri. THOD 1994;4:77-85
  7. Taghian AG, Powell SN. The role of radiation therapy for breast cancer. Surg Clin North Am 1999;79;1091-115
  8. Recht A, Barteline H, Fourquet A, et al. Postmastectomy radiotherapy: Questions for the twenty-first century. J Clin Oncol 1998;16:2886-9
  9. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:1689-700
  10. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55
  11. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62
  12. Demicheli R, Miceli R, Brambilla C, et al. Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant CMF. Data supporting the occurrence of ''cures''. Breast Cancer Res Treat 1999;53:209-15
  13. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999;17:1080-2
  14. Demicheli R, Abbatista A, Miceli R, et al. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat 1996;41:177-85
  15. Falkson G, Gelman